Summit X LLC’s Sana Biotechnology SANA Stock Holding History

Summit X LLC’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-42,665	Closed	-$116K	–	190
2025 Q2	$116K	Buy	42,665 +6,665	+19%	+$13.8K	0.02%	253
2025 Q1	$60.5K	Buy	+36,000	New	+$101K	0.01%	239

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit X LLC's SANA Position: Q3 2025 in Review

Summit X LLC sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 42,665 shares — an estimated $116K sold.

Summit X LLC first reported a position in SANA in Q1 2025 and held it in 2 quarters. The position peaked at $116K in Q2 2025. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

Summit X LLC reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
Summit X LLC sold 42,665 Sana Biotechnology shares in Q3 2025, an estimated $116K.
Summit X LLC first reported a position in Sana Biotechnology in Q1 2025 and held it in 2 quarters.
Summit X LLC's Sana Biotechnology position peaked at $116K in Q2 2025.
178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.